105955-01-9
105955-01-9
Chemical Structure
KS370G
- CAS No.: 105955-01-9
- Formula:C17H17NO3
- Molecular Weight:283.32
IUPAC Name: (E)-3-(3,4-dihydroxyphenyl)-N-phenethylacrylamide
InChIKey: QOWABIXYAFJMQE-VQHVLOKHSA-N
SMILES: O=C(/C=C/C1=CC=C(C(O)=C1)O)NCCC2=CC=CC=C2
Biological Activity: KS370G is an orally active hypoglycemic and cardiovascular protective agent. KS370G improves left ventricular hypertrophy and function in pressure-overload mice heart. KS370G reduces renal obstructive nephropathy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
KS370G | 99.71% | KS370G is an orally active hypoglycemic and cardiovascular protective agent. KS370G improves left ventricular hypertrophy and function in pressure-overload mice heart. KS370G reduces renal obstructive nephropathy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Chuang ST, et al. KS370G, a caffeamide derivative, attenuates unilateral ureteral obstruction-induced renal fibrosis by the reduction of inflammation and oxidative stress in mice. Eur J Pharmacol. 2015 Mar 5;750:1-7. [Content Brief]
- [2]. Weng YC, et al. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart. Eur J Pharmacol. 2012 Jun 5;684(1-3):108-15. [Content Brief]
